Skip to main content
SpringerLink
Log in

Adalimumab/mesalazine

Diffuse interstitial lung disease and granulomatous lesion: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Auffret M, et al. Mesalazine-related interstitial lung disease: an under-diagnosed effect?]. . Therapie 69: 531-2, No. 6, Nov 2014 [French: summarized from English translation] - France

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/mesalazine. Reactions Weekly 1543, 20 (2015). https://doi.org/10.1007/s40278-015-8644-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-8644-y

Search

Navigation